This branch of medicine develops methods to repair or replace damaged cells, tissues, or organs. This can include innovative methods such as stem cell-based treatments. Europe has one of the largest regenerative medicine ecosystems in the world. Since the exit of the U.K from the E.U, it is yet to be seen how the UKs policies surrounding regenerative medicine, including stem cellCells that can proliferate indefinitely and differentiate into many different cell types, ranging fr and clinical trial policies, will differ from the EU. Market opportunities are expected to see a boost with the UK’s ageing population and increasing incidence of diseases with unmet clinical needs such as Parkinson’s disease, stroke and heart failure.